SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-025938
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:46
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_chinapharma.htm   iXBRL 10-Q 429272
2 CERTIFICATION f10q0322ex31-1_chinapharma.htm EX-31.1 8179
3 CERTIFICATION f10q0322ex31-2_chinapharma.htm EX-31.2 8398
4 CERTIFICATION f10q0322ex32-1_chinapharma.htm EX-32.1 5432
  Complete submission text file 0001213900-22-025938.txt   3278379

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20220331.xsd EX-101.SCH 42732
6 XBRL CALCULATION FILE cphi-20220331_cal.xml EX-101.CAL 39223
7 XBRL DEFINITION FILE cphi-20220331_def.xml EX-101.DEF 180292
8 XBRL LABEL FILE cphi-20220331_lab.xml EX-101.LAB 361901
9 XBRL PRESENTATION FILE cphi-20220331_pre.xml EX-101.PRE 189576
55 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_chinapharma_htm.xml XML 261110
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 22917788
SIC: 2834 Pharmaceutical Preparations